Compounded Pergolide Comparisons (AAEP 2010)

Systemic effects of equine Cushing's disease, a common malady in older horses, have been controlled well in many horses with daily administration of pergolide. Until 2007 this medication was available for off-label use--the human product was available for purchase. Then, the FDA-approved product was removed from the human pharmaceutical market. The product had to be compounded in order to be

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners